Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 11719
TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642537(US20230414794, Compound S2)
Affinity DataKi:  0.0800nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM50304738(2-(3-((S)-1-carboxy-3-methylbutyl)ureido)pentanedi...)
Affinity DataKi:  3.53nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642538(US20230414794, Compound S3)
Affinity DataKi:  5.69nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642536(US20230414794, Compound S1)
Affinity DataKi:  5.96nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642539(US20230414794, Comparative Compound DS1)
Affinity DataKi: >1.00E+3nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642540(US20230414794, Comparative Compound DS2)
Affinity DataKi: >1.00E+3nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642541(US20230414794, Comparative Compound DS4 | US202304...)
Affinity DataKi: >1.00E+3nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent

TargetGlutamate carboxypeptidase 2(Human)
Peking University First Hospital

US Patent
LigandPNGBDBM642541(US20230414794, Comparative Compound DS4 | US202304...)
Affinity DataKi: >1.00E+3nMAssay Description:This test example is used to display the results of the PSMA inhibitory activity tested for each compound and comparative compound. A LNCaP cell lysa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2024
Entry Details
Go to US Patent